Exhibit 4.2


 


SUPPLEMENTAL INDENTURE


 


SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of
February 12, 2004, among the entities listed on Annex A hereto (each a “New
Subsidiary Guarantor” and each a “Subsidiary Guarantor” (as defined in the Indenture)),
each of which is a Subsidiary of AmeriPath, Inc., a Delaware corporation (the
“Company”), the Company, AmeriPath Holdings, Inc., a Delaware corporation
(“Holdings”), the other Subsidiary Guarantors and U.S. Bank National
Association, as Trustee under the Indenture (the “Trustee”).


 


W  I  T  N  E  S
S  E  T  H:


 


WHEREAS, the Company has heretofore executed and delivered to the
Trustee an indenture (the “Indenture”), dated as of March 27, 2003, providing
for the issuance of 10-1⁄2% Senior Subordinated Notes due 2013 (the “Securities”);


 


WHEREAS, pursuant to Section 4.11 of the
Indenture, the Company is required to cause each Foreign Restricted Subsidiary
that Guarantees any other Indebtedness of the Company and each Domestic
Restricted Subsidiary that Incurs any Indebtedness (other than in the case of
any Consolidated Managed Subsidiary, Indebtedness owed to the Company or any
Subsidiary Guarantor) to execute and deliver to the Trustee a Guaranty
Agreement pursuant to which such Restricted Subsidiary shall Guarantee payment
of the Securities on the same terms and conditions as those set forth in the
Indenture;


 


WHEREAS, pursuant to Section 9.01(4) of the Indenture, the Trustee is
authorized to execute and deliver this Supplemental Indenture; and


 


WHEREAS, each of the New Subsidiary Guarantors is a direct or indirect
Subsidiary of the Company as set forth on Annex A hereto.


 


NOW THEREFORE, in consideration of the foregoing and for good and
valuable consideration, the receipt of which is hereby acknowledged, the
Company, each New Subsidiary Guarantor, Holdings, the other Subsidiary
Guarantors and the Trustee mutually covenant and agree for the equal and
ratable benefit of the Holders of the Securities as follows:


 


SECTION 1.  Capitalized
Terms.  Capitalized terms used
herein but not defined shall have the meanings assigned to them in the
Indenture.


 


SECTION 2.  Guaranties.  Each New Subsidiary Guarantor hereby
unconditionally and irrevocably guarantees, jointly and severally with the
other Subsidiary Guarantors, to each Holder and to the Trustee and its
successors and assigns (a) the full and punctual payment of principal of and
interest on the Securities when due, whether at maturity, by acceleration, by
redemption or otherwise, and all other monetary obligations of the Company
under the Indenture and the Securities and (b) the full and punctual
performance within applicable grace periods of all other obligations of the
Company under the Indenture and the Securities (all the foregoing being
hereinafter collectively called the “Guaranteed Obligations”).  Each New Subsidiary Guarantor further agrees
that the Guaranteed Obligations may be extended


 

















 


or renewed, in whole or in part, without
notice to or further assent from such Subsidiary Guarantor and that such Subsidiary
Guarantor will remain bound under this Supplemental Indenture notwithstanding
any extension or renewal of any Guaranteed Obligation.


 


Each New Subsidiary Guarantor waives presentation to, demand of,
payment from and protest to the Company of any of the Guaranteed Obligations
and also waives notice of protest for nonpayment. Each New Subsidiary Guarantor
waives notice of any default under the Securities or the Guaranteed
Obligations.  The obligations of each New
Subsidiary Guarantor hereunder shall not be affected by (a) the failure of any
Holder or the Trustee to assert any claim or demand or to enforce any right or
remedy against the Company or any other Person under the Indenture, this
Supplemental Indenture, the Securities or any other agreement or otherwise; (b)
any extension or renewal of any thereof; (c) any rescission, waiver, amendment
or modification of any of the terms or provisions of the Indenture, this
Supplemental Indenture, the Securities or any other agreement; (d) the release
of any security held by any Holder or the Trustee for the Guaranteed
Obligations or any of them; (e) the failure of any Holder or the Trustee to
exercise any right or remedy against any other guarantor of the Guaranteed
Obligations; or (f) except as set forth in Section 11.06 of the Indenture, any
change in the ownership of such Subsidiary Guarantor.


 


Each New Subsidiary Guarantor further agrees that its Subsidiary
Guaranty herein constitutes a guarantee of payment, performance and compliance
when due (and not a guarantee of collection) and waives any right to require
that any resort be had by any Holder or the Trustee to any security held for
payment of the Guaranteed Obligations.


 


The Subsidiary Guaranties of the New Subsidiary Guarantors are, to the
extent and in the manner set forth in Article 12 of the Indenture,
subordinated and subject in right of payment to the prior payment in full of
the principal of and premium, if any, and interest on all Senior Indebtedness
of such Subsidiary Guarantors and such Subsidiary Guaranties are made subject
to the provisions of the Indenture.


 


Except as expressly set forth in Section 8.01(b), 11.02 and 11.06 of
the Indenture, the obligations of each New Subsidiary Guarantor hereunder shall
not be subject to any reduction, limitation, impairment or termination for any
reason, including any claim of waiver, release, surrender, alteration or
compromise, and shall not be subject to any defense of setoff, counterclaim,
recoupment or termination whatsoever or by reason of the invalidity, illegality
or unenforceability of the Guaranteed Obligations or otherwise. Without
limiting the generality of the foregoing, the obligations of each New
Subsidiary Guarantor herein shall not be discharged or impaired or otherwise
affected by the failure of any Holder or the Trustee to assert any claim or
demand or to enforce any remedy under the Indenture, this Supplemental
Indenture, the Securities or any other agreement, by any waiver or modification
of any thereof, by any default, failure or delay, wilfull or otherwise, in the
performance of the Guaranteed Obligations, or by any other act or thing or
omission or delay to do any other act or thing which may or might in any manner
or to any extent vary the risk of such Subsidiary Guarantor or would otherwise
operate as a discharge of such Subsidiary Guarantor as a matter of law or
equity.


 


Each New Subsidiary Guarantor further agrees that its Guarantee herein
shall continue to be effective or be reinstated, as the case may be, if at any
time payment, or any part thereof, of principal of or interest on any
Guaranteed Obligation is rescinded or must otherwise


 


2

















 


be restored by any Holder or the Trustee upon
the bankruptcy or reorganization of the Company or otherwise.


 


In furtherance of the foregoing and not in limitation of any other
right which any Holder or the Trustee has at law or in equity against any New
Subsidiary Guarantor by virtue hereof, upon the failure of the Company to pay
the principal of or interest on any Guaranteed Obligation when and as the same
shall become due, whether at maturity, by acceleration, by redemption or
otherwise, or to perform or comply with any other Guaranteed Obligation, each
New Subsidiary Guarantor hereby promises to and shall, upon receipt of written
demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the
Holders or the Trustee an amount equal to the sum of (1) the unpaid amount of
such Guaranteed Obligations, (2) accrued and unpaid interest on such Guaranteed
Obligations (but only to the extent not prohibited by law) and (3) all other
monetary Guaranteed Obligations of the Company to the Holders and the Trustee.


 


Each New Subsidiary Guarantor agrees that it shall not be entitled to
any right of subrogation in respect of any Guaranteed Obligations guaranteed
hereby until payment in full of all Guaranteed Obligations and all obligations
to which the Guaranteed Obligations are subordinated as provided in
Article 12 of the Indenture.  Each
New Subsidiary Guarantor agrees that, as between it, on the one hand, and the
Holders and the Trustee, on the other hand, (x) the maturity of the Guaranteed
Obligations may be accelerated as provided in Article 6 of the Indenture for
the purposes of such Subsidiary Guarantor’s Subsidiary Guaranty herein,
notwithstanding any stay, injunction or other prohibition preventing such
acceleration in respect of the Guaranteed Obligations, and (y) in the event of
any declaration of acceleration of such Guaranteed Obligations as provided in
Article 6 of the Indenture, such Guaranteed Obligations (whether or not due and
payable) shall forthwith become due and payable by such Subsidiary Guarantor
for the purposes of this Supplemental Indenture.


 


Each New Subsidiary Guarantor also agrees to pay any and all costs and
expenses (including reasonable attorneys’ fees) incurred by the Trustee or any
Holder in enforcing any rights under this Section 2.


 


SECTION 3.  Limitation on
Liability.  Any term or provision of
this Supplemental Indenture to the contrary notwithstanding, the maximum
aggregate amount of the Guaranteed Obligations by any New Subsidiary Guarantor
shall not exceed the maximum amount that can be hereby guaranteed without
rendering this Supplemental Indenture, as it relates to such Subsidiary
Guarantor, voidable under applicable law relating to fraudulent conveyance,
fraudulent transfer or similar laws affecting the rights of creditors
generally.


 


SECTION 4.  Successors and
Assigns.  This Supplemental
Indenture shall be binding upon each New Subsidiary Guarantor and its
successors and assigns and shall inure to the benefit of the successors and
assigns of the Trustee and the Holders and, in the event of any transfer or
assignment of rights by any Holder or the Trustee, the rights and privileges
conferred upon that party in this Supplemental Indenture and in the Securities
shall automatically extend to and be vested in such transferee or assignee, all
subject to the terms and conditions of this Supplemental Indenture.


 


SECTION 5.  No Waiver.  Neither a failure nor a delay on the part of
either the Trustee or the Holders in exercising any right, power or privilege
under this Supplemental


 


3

















 


Indenture shall operate as a waiver thereof,
nor shall a single or partial exercise thereof preclude any other or further
exercise of any right, power or privilege. The rights, remedies and benefits of
the Trustee and the Holders herein expressly specified are cumulative and not
exclusive of any other rights, remedies or benefits which either may have under
this Supplemental Indenture at law, in equity, by statute or otherwise.


 


SECTION 6.  Modification.  No modification, amendment or waiver of any
provision of this Supplemental Indenture, nor the consent to any departure by
any New Subsidiary Guarantor therefrom, shall in any event be effective unless
the same shall be in writing and signed by the Trustee, and then such waiver or
consent shall be effective only in the specific instance and for the purpose
for which given.  No notice to or demand
on any New Subsidiary Guarantor in any case shall entitle such Subsidiary
Guarantor to any other or further notice or demand in the same, similar or
other circumstances.


 


SECTION 7.  Release.  Upon


 


(i)            the
sale (including any sale pursuant to any exercise of remedies by a holder of
Senior Indebtedness of the Company or of such New Subsidiary Guarantor) or
other disposition (including by way of consolidation or merger) of a New
Subsidiary Guarantor,


 


(ii)           the
sale or disposition of all or substantially all the assets of a New Subsidiary
Guarantor or


 


(iii)          upon
the designation of a New Subsidiary Guarantor as an Unrestricted Subsidiary
pursuant to the terms of the Indenture,


 


such
New Subsidiary Guarantor shall be deemed released from all obligations under
this Supplemental Indenture without any further action required on the part of
the Trustee or any Holder, in each case other than a sale or disposition to
Parent or a Subsidiary of Parent, provided, however, in the case
of clauses (i) and (ii) above, the Company provides an Officers’ Certificate to
the Trustee to the effect that the Company will comply with its obligations
under Section 4.06 of the Indenture.


 


SECTION 8.  Contribution.  The New Subsidiary Guarantors shall be
entitled upon payment in full of all guarantied obligations under this
Supplemental Indenture to a contribution from each other Subsidiary Guarantor
in an amount equal to such other Subsidiary Guarantor’s pro rata portion of
such payment based on the respective net assets of all the Subsidiary
Guarantors at the time of such payment determined in accordance with GAAP.


 


SECTION 9.  Governing Law.  This Supplemental Indenture shall be
governed by, and construed in accordance with, the laws of the State of New
York.


 


SECTION 10.  No Recourse
Against Others.  A director,
officer, employee, incorporator, partner, stockholder, member or manager, as
such, of any New Subsidiary Guarantor shall not have any liability for any
obligations of Parent or the Company under the Securities or the Indenture or
of such New Subsidiary Guarantor under its Subsidiary Guaranty, the Indenture
or this Supplemental Indenture or for any claim based on, in respect of or by
reason


 


4

















 


of such obligations or their creation.  By accepting a Security, each Holder waives
and releases all such liability.  The
waiver and release shall be part of the consideration for the issue of the
Securities.


 


SECTION 11.  Multiple
Originals.  The parties may sign any
number of copies of this Supplemental Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement.  One signed copy is enough to prove this
Supplemental Indenture.


 


SECTION 12.  Headings.  The headings of the Sections of this
Supplemental Indenture have been inserted for convenience of reference only,
are not intended to be considered a part hereof and shall not modify or
restrict any of the terms or provisions hereof.


 


[SIGNATURE PAGES FOLLOW]


 


5

















 


IN WITNESS WHEREOF, the
parties have caused this Supplemental Indenture to be duly executed as of the
date first written above.


 


 


	
   

  	
  AMERIPATH
  HOLDINGS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  SCOTT MACKESY

  	
   

  
	
   

  	
   

  	
  Name: Scott
  Mackesy

  
	
   

  	
   

  	
  Title: Vice
  President, Treasurer and Secretary

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  AMERIPATH,
  INC.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title:
  Executive Vice President and CFO

  



 

















 


	
   

  	
  3-GEN
  DIAGNOSTIC LABORATORIES, INC.

  (a Utah corporation)

  
	
   

  	
  AMERIPATH
  5.01(a) CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  AMERIPATH
  CINCINNATI, INC.

  (an Ohio corporation)

  
	
   

  	
  AMERIPATH
  CLEVELAND, INC.

  (an Ohio corporation)

  
	
   

  	
  AMERIPATH
  CONSOLIDATED LABS, INC.

  (a Florida corporation)

  
	
   

  	
  AMERIPATH
  KENTUCKY, INC.

  (a Kentucky corporation)

  
	
   

  	
  AMERIPATH
  LUBBOCK 5.01(a)

  CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  AMERIPATH
  MARKETING USA, INC.

  (a Florida corporation)

  
	
   

  	
  AMERIPATH
  MICHIGAN, INC.

  (a Michigan corporation)

  
	
   

  	
  AMERIPATH
  MISSISSIPPI, INC.

  (a Mississippi corporation)

  
	
   

  	
  AMERIPATH
  NEW ENGLAND, INC.

  (a Delaware corporation)

  
	
   

  	
  AMERIPATH
  NORTH CAROLINA, INC.

  (a North Carolina corporation)

  
	
   

  	
  AMERIPATH
  OHIO, INC.

  (a Delaware corporation)

  
	
   

  	
  AMERIPATH
  PAT 5.01(a) CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  AMERIPATH
  PCC, INC.

  (an Ohio corporation)

  
	
   

  	
  AMERIPATH
  PHILADELPHIA, INC.

  (a New Jersey corporation)

  
	
   

  	
  AMERIPATH
  SC, INC.

  (a South Carolina corporation)

  
	
   

  	
  AMERIPATH
  SEVERANCE 5.01(a)

  CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  AMERIPATH
  YOUNGSTOWN LABS, INC.

  (an Ohio corporation)

  



 


[Signature Page to the Supplemental Indenture]


 

















 


	
   

  	
  AMERIPATH
  YOUNGSTOWN, INC.

  (an Ohio corporation)

  
	
   

  	
  ANATOMIC
  PATHOLOGY SERVICES, INC.

  (an Oklahoma corporation)

  
	
   

  	
  ARIZONA
  PATHOLOGY GROUP, INC.

  (an Arizona corporation)

  
	
   

  	
  ARLINGTON
  PATHOLOGY ASSOCIATION

  5.01(a) CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  CPA I, INC.

  (a Tennessee corporation)

  
	
   

  	
  CPA II, INC.

  (a Tennessee corporation)

  
	
   

  	
  DERMATOPATHOLOGY
  SERVICES, INC.

  (an Alabama corporation)

  
	
   

  	
  DFW 5.01(a)
  CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  KAILASH B.
  SHARMA, M.D., INC.

  (a Georgia corporation)

  
	
   

  	
  NAPA 5.01(a)
  CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  OCMULGEE
  MEDICAL PATHOLOGY

  ASSOCIATION, INC.

  (a Georgia corporation)

  
	
   

  	
  PCA OF
  COLUMBUS, INC.

  (a Tennessee corporation)

  
	
   

  	
  PCA OF
  DENVER, INC.

  (a Tennessee corporation)

  
	
   

  	
  PCA OF LOS
  GATOS, INC.

  (a Tennessee corporation)

  
	
   

  	
  PCA OF
  MEMPHIS, INC.

  (a Tennessee corporation)

  
	
   

  	
  PCA OF
  NASHVILLE, INC.

  (a Tennessee corporation)

  
	
   

  	
  PCA OF ST.
  LOUIS II, INC.

  (a Tennessee corporation)

  
	
   

  	
  PCA
  SOUTHEAST II, INC.

  (a Tennessee corporation)

  
	
   

  	
  PETER G.
  KLACSMANN, M.D., INC.

  (a Georgia corporation)

  



 

















 


	
   

  	
  SHARON G.
  DASPIT, M.D., INC.

  (a Georgia corporation)

  
	
   

  	
  SHOALS
  PATHOLOGY ASSOCIATES, INC.

  (an Alabama corporation)

  
	
   

  	
  SIMPSON PATHOLOGY
  5.01(a)

  CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
  STRIGEN,
  INC.

  (a Utah corporation)

  
	
   

  	
  TID
  ACQUISITION CORP.

  (a Delaware corporation)

  
	
   

  	
  TXAR 5.01(a)
  CORPORATION

  (a Texas not-for-profit corporation)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title: Vice
  President

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  AMERIPATH
  INDIANA, LLC

  (an Indiana limited liability company)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  AmeriPath,
  Inc.,

  
	
   

  	
   

  	
  its Managing
  Member

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title:
  Executive Vice President and CFO

  



 

















 


	
   

  	
  AMERIPATH,
  LLC

  (a Delaware limited liability company)

  
	
   

  	
  API NO. 2,
  LLC

  (a Delaware limited liability company)

  
	
   

  	
  ROCKY
  MOUNTAIN PATHOLOGY, L.L.C.

  (a Utah limited liability company)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title: Sole
  Manager

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  AMERIPATH
  TEXAS, LP

  (a Delaware limited partnership)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  AmeriPath,
  LLC,

  
	
   

  	
   

  	
  its General
  Partner

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title: Sole
  Manager

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  COLUMBUS PATHOLOGY
  ASSOCIATES

  (a Mississippi general partnership)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  CPA I, Inc.,

  
	
   

  	
   

  	
  its general
  partner

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ DAVID L.
  REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title: Vice
  President

  
					



 

















 


	
   

  	
  NUCLEAR
  MEDICINE AND PATHOLOGY

  ASSOCIATES

  (a Georgia general partnership)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  Peter G.
  Klacsmann, M.D., Inc.,

  
	
   

  	
   

  	
  its general
  partner

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title: Vice
  President

  



 

















 


	
   

  	
  NEW
  SUBSIDIARY GUARANTORS:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  AMERIPATH
  FLORIDA, LLC

  (a Delaware limited liability company)

  
	
   

  	
  AMERIPATH
  NEW YORK, LLC

  (a Delaware limited liability company)

  
	
   

  	
  AMERIPATH
  PENNSYLVANIA, LLC

  (a Pennsylvania limited liability company)

  
	
   

  	
  AMERIPATH
  WISCONSIN, LLC

  (a Wisconsin limited liability company)

  
	
   

  	
  DIAGNOSTIC
  PATHOLOGY MANAGEMENT

  SERVICES, LLC

  (an Oklahoma limited liability company)

  
	
   

  	
  O’QUINN
  MEDICAL PATHOLOGY

  ASSOCIATION, LLC

  (a Georgia limited liability company)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  AmeriPath,
  Inc.,

  
	
   

  	
   

  	
  its Managing
  Member

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title:
  Executive Vice President and CFO

  



 

















 


	
   

  	
  REGIONAL
  PATHOLOGY

  CONSULTANTS, LLC

  (a Utah limited liability company)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  Strigen,
  Inc.,

  
	
   

  	
   

  	
  Its Managing
  Member

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
    /s/
  DAVID L. REDMOND

  	
   

  
	
   

  	
   

  	
  Name: David
  L. Redmond

  
	
   

  	
   

  	
  Title: Vice
  President

  



 

















 


	
   

  	
  U.S. BANK
  NATIONAL ASSOCIATION,

  as Trustee

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ RICHARD
  PROKOSCH

  	
   

  
	
   

  	
   

  	
  Name:
  Richard Prokosch

  
	
   

  	
   

  	
  Title: Vice
  President

  



 

















 


ANNEX A


 


New Subsidiary Guarantors


 


AmeriPath Florida, LLC


AmeriPath Pennsylvania, LLC


AmeriPath Wisconsin, LLC


AmeriPath New York, LLC


Diagnostic Pathology Management
Services, LLC


O’Quinn Medical Pathology, LLC


Regional Pathology Consultants,
LLC